Pancreatic Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People diagnosed with stage I–IV colorectal cancer, or colorectal cancer that has come back (Arm 1)
• People who can speak, read, and write in English (Pre-pilot phase, Arms 1–4)
• People who are able to give informed consent to participate (Pre-pilot phase, Arms 1–4, PCS study)
• People who live in the Houston area, specifically Harris County or a neighbouring county (Pre-pilot phase)
• People who are generally active and able to care for themselves — specifically, those up and about for more than half of their waking hours (Arm 1)
• People diagnosed with certain head and neck cancers at specific stages, including oropharyngeal, hypopharyngeal, nasopharyngeal, salivary gland, oral cavity, laryngeal, or unknown primary head and neck cancer with spread to the neck — or other head and neck cancers approved by a collaborating doctor (Arms 2 and 3)
• People who have had any cancer diagnosis, other than a type of skin cancer called non-melanoma skin cancer (Arm 4)
• People who reported being a current smoker or someone who recently quit smoking when admitted to MD Anderson Cancer Center (Arm 4)
• People who have a valid home address and a working home phone number (Arm 4)
• People who live in the Houston area or surrounding region during the period of the study (Arms 1–4)
• People who are scheduled to have surgery to remove part of the pancreas for pancreatic cancer, pancreatic neuroendocrine tumours, or pancreatic cysts (whether cancerous or non-cancerous) (PCS study)
• People who are fluent in English (PCS study and TAPS study)
• People who have access to a telephone and agree to communicate with the research team by phone (PCS study)
• People diagnosed with a solid tumour that has spread or cannot be surgically removed (TAPS study)
• People aged 18 years or older (TAPS study)
• People whose physical functioning falls within a certain range, from fully active to limited self-care ability (ECOG score 0–3) (TAPS study)

Who may not be able to join:

• People who have had major surgery within the past 8 weeks (Arms 1 and 4)
• People who report having high blood pressure that is not being monitored or managed by a doctor (Pre-pilot phase, Arms 1–3)
• People who show clear signs of significant confusion, such as not knowing the time, where they are, or who they are (Arms 1–4 and TAPS study)
• People with a physical condition affecting their bones, nerves, or muscles that would prevent them from standing on a weight scale (Pre-pilot phase, Arm 2)
• People who are not currently receiving radiation treatment for one of the cancers listed in the study's specific criteria (Arms 2 and 3)
• People who are mostly inactive or unable to care for themselves (Arms 2 and 3)
• People currently receiving treatment for a cancer not listed in the study's specific criteria — though treatment for non-melanoma skin cancer is not a reason for exclusion (Arms 2 and 3)
• People who have an existing swallowing difficulty that is unrelated to their cancer diagnosis, such as a swallowing problem caused by a nerve or neurological condition (Arm 3 only)
• People with an active substance use disorder, whether formally diagnosed or strongly suspected (Arm 4)
• People already enrolled in a specific related study called protocol 2014-0712 (PCS study)
• People who do not have internet access at home (PCS study)
• People who do not have a home WiFi connection (PCS study)
• People whose pre-surgical assessment suggests a high risk that surgery will not achieve its intended treatment goal (PCS study) (confirm with trial site)
• People with an unstable heart or lung condition, or significant heart disease affecting daily function (PCS study)
• People with a recent bone fracture or muscle/joint injury that prevents them from putting full weight through all four limbs for exercise (PCS study)
• People with poorly controlled pain rated 7 out of 10 or higher at the time of enrolment (PCS study)
• People with a muscle or joint disease that affects physical function (PCS study)
• People who have a pacemaker or other internal medical device, or who are pregnant (PCS study)
• People already enrolled in a specific related study called protocol 2017-0198 (PCS study)

Important: Always verify eligibility with the trial site directly before applying.